Source: JHVEPhoto / Shutterstock.com
Avidity Biosciences (NASDAQ:RNA) just reported results for the first quarter of 2024.
- Avidity Biosciences reported earnings per share of -79 cents. This was below the analyst estimate for EPS of -78 cents.
- The company reported revenue of $3.54 million.
- This was 38.40% better than the analyst estimate for revenue of $2.56 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/rna-stock-earnings-avidity-biosciences-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC